1. Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma. Issue 13 (25th September 2017) Authors: Noble, F; Lloyd, M A; Turkington, R; Griffiths, E; O'Donovan, M; O'Neill, J R; Mercer, S; Parsons, S L; Fitzgerald, R C; Underwood, T J; Noorani, A; Fels Elliott, R; Abdullahi, Z; de la Rue, R; Bornschein, J; MacRae, S; Nutzinger, B; Grehan, N; Contino, G; Crawte, J Journal: British journal of surgery Issue: Volume 104:Issue 13(2017) Page Start: 1816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-017 TRIM44: from prognosis to therapy in oesophageal adenocarcinoma and breast cancer. (28th May 2012) Authors: Ong, C A J; Shannon, N B; Lao-Sirieix, P; Ross-Innes, C; O'Donovan, M; Rueda, O M; Walker, C E; Noorani, A; Hardwick, R; Caldas, C; Fitzgerald, R C Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PTU-128 Novel insights into metastatic spread of oesophageal adenocarcinoma from whole genome sequencing data. (22nd June 2015) Authors: Noorani, A; Wedge, D; Lao-Sirieix, P; Weaver, J; Grehan, N; Debiram, I; Gilligan, D; Hindmarsh, A; Goddard, M; Hardwick, R; Fitzgerald, R Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗